![4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide](https://static.cymitquimica.com/products/3D/img/VJB07055.png "Haga clic para ampliar")
4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide
CAS: 870070-55-6
Ref. 3D-VJB07055
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
- Tozadenant
- 4-Hydroxy-4-Methyl-Piperidine-1-Carboxylic Acid(4-Methoxy-7-Morpholin-4-Yl-Benzothiazol-2-Yl)-Amide
- Syn-115
- 4-Hydroxy-N-(4-Methoxy-7-(4-Morpholinyl)-2-Benzothiazolyl)-4-Methyl-1-Piperidinecarboxamide
- Tozadenant (USAN)
- 4-Hydroxy-N-(4-methoxy-7-morpholinobenzo(d)thiazol-2-yl)-4-methylpiperidine-1-carboxamide
4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide is a novel, potent, and selective adenosine receptor antagonist. It has been shown to be well tolerated in preclinical models and demonstrate efficacy in animal models of infectious diseases. Preclinical studies have also demonstrated that administration of this drug results in a stable plasma concentration with a low incidence of adverse effects. Clinical trials are currently underway to evaluate the safety and efficacy of this drug for the treatment of cancer and other diseases.
Propiedades químicas
Consulta técnica sobre: 3D-VJB07055 4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
